{"hands_on_practices": [{"introduction": "A spatial transcriptomics experiment generates a beautiful but abstract map of gene expression clusters across an embryo. The first and most crucial step in making sense of this map is to assign biological identities to these clusters. This practice challenges you to apply your foundational knowledge of developmental biology to this task, using well-established \"marker genes\" to identify the primary germ layers within a spatially resolved dataset [@problem_id:1715345]. Mastering this skill is essential for orienting yourself within the molecular landscape of the embryo.", "problem": "A developmental biology research team is studying gastrulation in a vertebrate embryo using a technique called spatial transcriptomics. This method allows them to measure the expression levels of all genes at thousands of distinct locations within a tissue slice of the embryo. After collecting the data, a computational algorithm identifies three large, spatially distinct clusters of cells, which they hypothesize correspond to the three primary germ layers: ectoderm, mesoderm, and endoderm.\n\nTo test this hypothesis and assign a definitive identity to each cluster, the team needs to check for the expression of well-known \"marker genes.\" A marker gene is a gene that is known from previous studies to be highly and specifically expressed in a particular cell type or tissue during a specific developmental stage. Their goal is to find the cluster representing the ectoderm. They examine the spatial expression patterns of several genes.\n\nWhich of the following genes would serve as the most specific and reliable marker for identifying the ectoderm cluster at the gastrula stage?\n\nA. *Actb* (Beta-actin)\n\nB. *T* (Brachyury)\n\nC. *MyoD* (Myogenic differentiation 1)\n\nD. *Sox2* (SRY-box transcription factor 2)\n\nE. *Gata4* (GATA binding protein 4)", "solution": "Goal: Identify the most specific and reliable marker gene for ectoderm at the gastrula stage using the criterion that a marker gene is highly and specifically expressed in the target tissue at the relevant developmental stage.\n\nEvaluate each option against specificity and stage-appropriateness:\n\n- Option A: *Actb* (Beta-actin) encodes a cytoskeletal protein that is ubiquitously expressed in essentially all cell types as a housekeeping gene. It lacks tissue specificity and therefore cannot distinguish ectoderm from mesoderm or endoderm. Hence, not a suitable ectoderm marker.\n\n- Option B: *T* (Brachyury) is a classic marker of mesoderm, especially the primitive streak and nascent mesoderm during gastrulation. Its expression is largely restricted to mesodermal progenitors and not ectoderm. Thus, it marks the mesoderm cluster, not ectoderm.\n\n- Option C: *MyoD* (Myogenic differentiation 1) is a master regulator for skeletal muscle lineage commitment, typically expressed later in paraxial mesoderm derivatives (somites) rather than early during gastrulation, and is not an ectoderm marker. It is neither specific to ectoderm nor appropriately expressed at the gastrula stage for broad ectoderm identification.\n\n- Option D: *Sox2* (SRY-box transcription factor 2) is expressed in the epiblast and becomes specifically enriched in neural ectoderm during gastrulation and neurulation. At the gastrula stage, *Sox2* is widely used as a neural ectoderm marker due to its high and relatively specific expression in the neural plate territory compared with mesoderm and endoderm. Among the listed options, it provides the most specific and reliable identification of ectodermal identity in a spatial transcriptomic dataset at this stage.\n\n- Option E: *Gata4* (GATA binding protein 4) is associated with endoderm and mesendoderm lineages (including visceral endoderm and early cardiac mesoderm). It is not specific to ectoderm and therefore marks non-ectodermal clusters.\n\nConclusion: Among the given choices, *Sox2* is the most specific and reliable marker for identifying the ectoderm cluster at the gastrula stage.", "answer": "$$\\boxed{D}$$", "id": "1715345"}, {"introduction": "Once you have annotated your spatial map and located a tissue of interest, the next step is discovery. How do you find the complete set of genes that uniquely defines that tissue? This exercise introduces you to Differential Gene Expression (DGE) analysis, a cornerstone computational technique used to statistically compare gene expression between your chosen cluster and the rest of the embryo [@problem_id:1715361]. This moves you from simply identifying a known tissue to uncovering the comprehensive genetic program that makes it unique.", "problem": "A developmental biologist is using a spatial transcriptomics platform to map gene expression in a developing mouse embryo. After data acquisition and initial quality control, the analysis pipeline groups the thousands of spatial measurement spots into distinct clusters based on their gene expression profiles. By correlating these clusters with an adjacent tissue histology stain, the biologist confidently identifies one cluster, let's call it 'Cluster M', that corresponds precisely to the metanephric mesenchyme, the progenitor tissue of the kidney.\n\nThe next major objective is to discover the \"marker genes\" for this tissueâ€”that is, the genes whose expression is significantly higher in Cluster M compared to all other clusters combined.\n\nWhich of the following computational methods is the most direct and appropriate next step to achieve this specific goal?\n\nA. Perform a Differential Gene Expression (DGE) analysis comparing the gene expression in Cluster M against all other clusters.\n\nB. Calculate a new Principal Component Analysis (PCA) on the expression data from all spots to find the components that best explain the variance.\n\nC. Select the 100 genes with the highest average expression within Cluster M and perform a Gene Ontology (GO) enrichment analysis on this list.\n\nD. Construct a gene co-expression network to identify modules of genes whose expression levels are correlated across the entire tissue slice.\n\nE. Apply a trajectory inference algorithm to order all spots along a developmental pseudotime to model the process of kidney differentiation.", "solution": "Goal clarification: The biologist wants marker genes for the metanephric mesenchyme, defined as genes whose expression is significantly higher in Cluster M than in all other clusters combined. This is a supervised, group-comparison problem: for each gene, test whether its expression is greater in Group 1 (Cluster M) than in Group 2 (all other spots).\n\nMapping the goal to a computational task: The standard and most direct approach is differential gene expression (DGE) analysis between predefined groups. This entails, for each gene, computing a test statistic comparing Cluster M versus the rest, estimating an effect size (e.g., log fold-change), and controlling for multiple testing to obtain statistically significant genes with positive effect size in Cluster M. In single-cell or spatial transcriptomics, commonly used tests include Wilcoxon rank-sum, likelihood-ratio tests from generalized linear models (e.g., negative binomial), or model-based methods that account for count distributions and covariates. The output is exactly the list of marker genes enriched in Cluster M.\n\nEvaluation of options:\n- Option A (DGE comparing Cluster M vs all other clusters) directly implements the required supervised contrast and yields significance, effect sizes, and multiple-testing control, matching the marker gene definition.\n- Option B (PCA) is unsupervised dimensionality reduction to capture global variance, not designed to identify genes specifically overexpressed in Cluster M, and does not provide per-gene differential statistics against the rest.\n- Option C (top 100 by average expression in Cluster M followed by GO) does not ensure specificity to Cluster M, lacks statistical comparison to other clusters, and GO enrichment is an annotation step after, not a method to discover markers with significance.\n- Option D (co-expression network) finds correlated modules across the tissue, not genes specifically upregulated in Cluster M relative to others.\n- Option E (trajectory inference) orders spots along pseudotime; it addresses dynamic processes rather than identifying static cluster-specific markers and is unnecessary for the stated goal.\n\nConclusion: The most direct and appropriate next step is Option A.", "answer": "$$\\boxed{A}$$", "id": "1715361"}, {"introduction": "Many developmental processes are not governed by sharp boundaries but by continuous molecular gradients that pattern tissues over a distance. This practice demonstrates how to use spatial transcriptomics data to test a quantitative model of such a process, specifically the diffusion of a signaling molecule from a source. By fitting a mathematical function to the gene expression data, you can estimate key physical parameters that describe the gradient's shape [@problem_id:1715313]. This advanced application shows how spatial data can move beyond mapping to provide deep, mechanistic insights into the principles of embryonic development.", "problem": "A developmental biologist is studying dorsoventral patterning in the neural tube of a chick embryo, a process controlled by signaling gradients. A key signaling molecule, Bone Morphogenetic Protein 4 (*Bmp4*), is secreted from a planar source at the roof plate (the most dorsal part of the neural tube) and diffuses ventrally, forming a concentration gradient. A simple, widely-used model based on source-diffusion-degradation dynamics suggests that the steady-state concentration of *Bmp4*, denoted $C(x)$, follows an exponential decay as a function of the distance $x$ from the source. The model is given by the equation:\n$$C(x) = A \\exp\\left(-\\frac{x}{\\lambda}\\right)$$\nwhere $x$ is the distance in micrometers ($\\mu m$) measured ventrally from the roof plate, $A$ is the effective concentration at the source, and $\\lambda$ is the characteristic decay length of the gradient. Background expression of *Bmp4* is considered negligible.\n\nUsing spatial transcriptomics, the biologist measures the *Bmp4* transcript levels, which are assumed to be directly proportional to the *Bmp4* protein concentration, at several positions along the dorsal-ventral axis. The following data points were obtained, where expression is quantified in normalized transcript counts (NTC):\n\n- At $x = 50.0 \\, \\mu m$, Expression = $150.0$ NTC\n- At $x = 100.0 \\, \\mu m$, Expression = $95.0$ NTC\n- At $x = 150.0 \\, \\mu m$, Expression = $55.2$ NTC\n- At $x = 200.0 \\, \\mu m$, Expression = $33.5$ NTC\n- At $x = 250.0 \\, \\mu m$, Expression = $20.3$ NTC\n\nTo quantify the gradient, you must determine the best-fit value for the characteristic decay length, $\\lambda$. Use the method of linear least squares on an appropriate transformation of the data to find this value.\n\nExpress your final answer for $\\lambda$ in micrometers ($\\mu m$), rounded to three significant figures.", "solution": "We are given the steady-state exponential model $C(x)=A\\exp(-x/\\lambda)$, with measured expression values proportional to $C(x)$. Taking the natural logarithm of both sides gives a linear relationship:\n$$\\ln C(x)=\\ln A-\\frac{1}{\\lambda}x.$$\nDefine $y=\\ln C$ and fit the linear model $y=b+mx$ by ordinary least squares, where $b=\\ln A$ and $m=-\\frac{1}{\\lambda}$. The least-squares slope for $n$ data points $(x_{i},y_{i})$ is\n$$m=\\frac{n\\sum x_{i}y_{i}-\\left(\\sum x_{i}\\right)\\left(\\sum y_{i}\\right)}{n\\sum x_{i}^{2}-\\left(\\sum x_{i}\\right)^{2}},\\quad \\text{and so} \\quad \\lambda=-\\frac{1}{m}.$$\n\nUsing the data $(x_{i},C_{i})$:\n- $x_{1}=50.0$, $C_{1}=150.0$ so $y_{1}=\\ln(150.0)\\approx 5.010635294$,\n- $x_{2}=100.0$, $C_{2}=95.0$ so $y_{2}=\\ln(95.0)\\approx 4.553876892$,\n- $x_{3}=150.0$, $C_{3}=55.2$ so $y_{3}=\\ln(55.2)\\approx 4.010962953$,\n- $x_{4}=200.0$, $C_{4}=33.5$ so $y_{4}=\\ln(33.5)\\approx 3.511545418$,\n- $x_{5}=250.0$, $C_{5}=20.3$ so $y_{5}=\\ln(20.3)\\approx 3.010620886$.\n\nCompute the sums:\n$n=5$, $\\sum x_{i}=750$, $\\sum x_{i}^{2}=137500$,\n$\\sum y_{i}\\approx 20.097641443$, $\\sum x_{i}y_{i}\\approx 2762.528202$.\n\nSubstitute into the slope formula:\n$$m=\\frac{5\\cdot 2762.528202-750\\cdot 20.097641443}{5\\cdot 137500-750^{2}}\\approx \\frac{-1260.590072}{125000}\\approx -0.0100847206.$$\n\nTherefore,\n$$\\lambda=-\\frac{1}{m}\\approx \\frac{1}{0.0100847206}\\approx 99.1599742.$$\n\nRounding to three significant figures gives $\\lambda\\approx 99.2$ in micrometers.", "answer": "$$\\boxed{99.2}$$", "id": "1715313"}]}